HIGHLIGHTS
- who: Corrado Pelaia and collaborators from the University Hospital of Cologne, Germany have published the paper: Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps, in the Journal: (JOURNAL) of 20/05/2021
- what: The aim of the present real-life observational investigation was to evaluate, in a larger sample of subjects with severe asthma, also including many patients with nasal polyposis, the therapeutic impact of dupilumab on upper and lower airway symptoms, severe asthma exacerbations, OCS intake and lung . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.